Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,666   1.18  Index Moved Down -0.07%
MMM CSCO AXP VZ PG Cleaning Small Growth Munis Real Estate 
United States  USA  |  Optimize Portfolios


Processing
Collecting data for ROSG and 300009 ...

Asset Comparison and Correlation

    
Investment horizon: 
  30 Days    Login   to change
 
 Rosetta Genomics Ltd.  vs   Anhui Anke Biotechnology Group
 Compare Fundamentals  
Daily Returns (%)
ROSG   300009   
 
Given investment horizon of 30 days, Rosetta Genomics Ltd is expected to generate 1.52 times more return on investment than Anhui. However, Rosetta is 1.52 times more volatile than Anhui Anke Biotechnology Group. It trades about 0.0 of its potential returns per unit of risk. Anhui Anke Biotechnology Group is currently generating about -0.05 per unit of risk. If you would invest  338.00  in Rosetta Genomics Ltd on April 21, 2013 and sell it today you would earn a total of  2.00  from holding Rosetta Genomics Ltd or generate 0.59% return on investment over 30 days.

Diversification

Good diversification
Overlapping area represents amount of risk that can be diversified away by holding Rosetta Genomics Ltd. and Anhui Anke Biotechnology Group in the same portfolio assuming nothing else is changed

Correlation Coefficient

-0.16
Parameters
Time Period1 Month [change]
DirectionNegative ROSG Moved Down vs 300009.SZ
StrengthInsignificant
Accuracy80.0%
ValuesDaily Returns
Follow Correlation between ROSG and 300009 with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Correlation between ROSG and 300009 to your reader
 
Share Correlation between ROSG and 300009 
Find Opportunities
 
Predicted Return Density
 
Returns   
ROSG   300009   

Rosetta Genomics Ltd

 
    
Rosetta
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Rosetta Genomics Ltd has generated negative risk-adjusted returns adding no value to investors with long positions.
    

Match ups for Rosetta

IDEXX Laboratories Inc vs. Rosetta Genomics Ltd
Neogen Corp vs. Rosetta Genomics Ltd
Abaxis Inc vs. Rosetta Genomics Ltd
Meridian Bioscience Inc vs. Rosetta Genomics Ltd
Quidel Corp vs. Rosetta Genomics Ltd
Synta Pharmaceuticals Corp vs. Rosetta Genomics Ltd
AMAG Pharmaceuticals Inc vs. Rosetta Genomics Ltd
SurModics Inc vs. Rosetta Genomics Ltd
Trinity Biotech plc vs. Rosetta Genomics Ltd
Nymox Pharmaceutical Corporation vs. Rosetta Genomics Ltd
  

Anhui Anke Biotechnology Group

 
    
Anhui
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Anhui Anke Biotechnology Group has generated negative risk-adjusted returns adding no value to investors with long positions.
    

Match ups for Anhui

Weichai Power Co Ltd vs. Anhui Anke Biotechnology Group
Zte Corporation vs. Anhui Anke Biotechnology Group
Zoomlion Heavy Industry Science and Technology Co Ltd vs. Anhui Anke Biotechnology Group
Jointown Pharmaceutical Group Co Ltd vs. Anhui Anke Biotechnology Group
Chongqing Tongjunge Co Ltd vs. Anhui Anke Biotechnology Group
Beijing Yanjing Brewery Co Ltd vs. Anhui Anke Biotechnology Group
Huatai Securities Co Ltd vs. Anhui Anke Biotechnology Group
GUANGZHOU AUTOMOBILE GROUP CNY1 vs. Anhui Anke Biotechnology Group
Xian Aircraft International Corporation vs. Anhui Anke Biotechnology Group
Shandong Chenming Paper Holdings Limited vs. Anhui Anke Biotechnology Group


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium